Mr. Miller has over 20 years experience in the diagnostic and biotechnology sectors, with in-depth experience in developing and implementing business strategies. Mr. Miller also has broad experience successfully leading reimbursement, sales, marketing and operations. Prior to joining Transgenomic, Mr. Miller provided consulting services to several diagnostic and biotechnology companies. Mr. Miller held the positions of Chief Commercial Officer at BG Medicine where he led the early commercialization of that company’s cardiac diagnostic assay Galectin-3 and President and Chief Commercial Officer at Mira Dx. He also held a variety of key positions within Athena Diagnostics with responsibilities for reimbursement, corporate accounts, business development, marketing and sales. His last position with Athena was as the Vice President of Sales & Marketing as that company grew from $6 million to over $100 million in sales.
Mr. Miller received a B.A. in Business Psychology from Miami University.